With TNFaip2 as a primary response gene of TNFα and highly expressed in immune cells, the decrease of TNFaip2 in CHRNA7KO BMDCs could be associated with a loss of responsiveness to inflammatory molecules in the tumor microenvironment of a CHRNA7KO host.33 This evidence concerns the gene TNFAIP2 and neoplasm.